Cargando…

Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin

BACKGROUND: Preterm prelabour rupture of the fetal membranes (PPROM) precedes 30% of preterm births and is a risk factor for early onset neonatal sepsis. As PPROM is strongly associated with ascending vaginal infection, prophylactic antibiotics are widely used. The evolution of vaginal microbiota co...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Richard G., Marchesi, Julian R., Lee, Yun S., Smith, Ann, Lehne, Benjamin, Kindinger, Lindsay M., Terzidou, Vasso, Holmes, Elaine, Nicholson, Jeremy K., Bennett, Phillip R., MacIntyre, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782380/
https://www.ncbi.nlm.nih.gov/pubmed/29361936
http://dx.doi.org/10.1186/s12916-017-0999-x
_version_ 1783295180531564544
author Brown, Richard G.
Marchesi, Julian R.
Lee, Yun S.
Smith, Ann
Lehne, Benjamin
Kindinger, Lindsay M.
Terzidou, Vasso
Holmes, Elaine
Nicholson, Jeremy K.
Bennett, Phillip R.
MacIntyre, David A.
author_facet Brown, Richard G.
Marchesi, Julian R.
Lee, Yun S.
Smith, Ann
Lehne, Benjamin
Kindinger, Lindsay M.
Terzidou, Vasso
Holmes, Elaine
Nicholson, Jeremy K.
Bennett, Phillip R.
MacIntyre, David A.
author_sort Brown, Richard G.
collection PubMed
description BACKGROUND: Preterm prelabour rupture of the fetal membranes (PPROM) precedes 30% of preterm births and is a risk factor for early onset neonatal sepsis. As PPROM is strongly associated with ascending vaginal infection, prophylactic antibiotics are widely used. The evolution of vaginal microbiota compositions associated with PPROM and the impact of antibiotics on bacterial compositions are unknown. METHODS: We prospectively assessed vaginal microbiota prior to and following PPROM using MiSeq-based sequencing of 16S rRNA gene amplicons and examined the impact of erythromycin prophylaxis on bacterial load and community structures. RESULTS: In contrast to pregnancies delivering at term, vaginal dysbiosis characterised by Lactobacillus spp. depletion was present prior to the rupture of fetal membranes in approximately a third of cases (0% vs. 27%, P = 0.026) and persisted following membrane rupture (31%, P = 0.005). Vaginal dysbiosis was exacerbated by erythromycin treatment (47%, P = 0.00009) particularly in women initially colonised by Lactobacillus spp. Lactobacillus depletion and increased relative abundance of Sneathia spp. were associated with subsequent funisitis and early onset neonatal sepsis. CONCLUSIONS: Our data show that vaginal microbiota composition is a risk factor for subsequent PPROM and is associated with adverse short-term maternal and neonatal outcomes. This highlights vaginal microbiota as a potentially modifiable antenatal risk factor for PPROM and suggests that routine use of erythromycin for PPROM be re-examined. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article 10.1186/s12916-017-0999-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5782380
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57823802018-02-06 Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin Brown, Richard G. Marchesi, Julian R. Lee, Yun S. Smith, Ann Lehne, Benjamin Kindinger, Lindsay M. Terzidou, Vasso Holmes, Elaine Nicholson, Jeremy K. Bennett, Phillip R. MacIntyre, David A. BMC Med Research Article BACKGROUND: Preterm prelabour rupture of the fetal membranes (PPROM) precedes 30% of preterm births and is a risk factor for early onset neonatal sepsis. As PPROM is strongly associated with ascending vaginal infection, prophylactic antibiotics are widely used. The evolution of vaginal microbiota compositions associated with PPROM and the impact of antibiotics on bacterial compositions are unknown. METHODS: We prospectively assessed vaginal microbiota prior to and following PPROM using MiSeq-based sequencing of 16S rRNA gene amplicons and examined the impact of erythromycin prophylaxis on bacterial load and community structures. RESULTS: In contrast to pregnancies delivering at term, vaginal dysbiosis characterised by Lactobacillus spp. depletion was present prior to the rupture of fetal membranes in approximately a third of cases (0% vs. 27%, P = 0.026) and persisted following membrane rupture (31%, P = 0.005). Vaginal dysbiosis was exacerbated by erythromycin treatment (47%, P = 0.00009) particularly in women initially colonised by Lactobacillus spp. Lactobacillus depletion and increased relative abundance of Sneathia spp. were associated with subsequent funisitis and early onset neonatal sepsis. CONCLUSIONS: Our data show that vaginal microbiota composition is a risk factor for subsequent PPROM and is associated with adverse short-term maternal and neonatal outcomes. This highlights vaginal microbiota as a potentially modifiable antenatal risk factor for PPROM and suggests that routine use of erythromycin for PPROM be re-examined. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article 10.1186/s12916-017-0999-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-24 /pmc/articles/PMC5782380/ /pubmed/29361936 http://dx.doi.org/10.1186/s12916-017-0999-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Brown, Richard G.
Marchesi, Julian R.
Lee, Yun S.
Smith, Ann
Lehne, Benjamin
Kindinger, Lindsay M.
Terzidou, Vasso
Holmes, Elaine
Nicholson, Jeremy K.
Bennett, Phillip R.
MacIntyre, David A.
Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
title Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
title_full Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
title_fullStr Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
title_full_unstemmed Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
title_short Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
title_sort vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782380/
https://www.ncbi.nlm.nih.gov/pubmed/29361936
http://dx.doi.org/10.1186/s12916-017-0999-x
work_keys_str_mv AT brownrichardg vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT marchesijulianr vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT leeyuns vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT smithann vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT lehnebenjamin vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT kindingerlindsaym vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT terzidouvasso vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT holmeselaine vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT nicholsonjeremyk vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT bennettphillipr vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin
AT macintyredavida vaginaldysbiosisincreasesriskofpretermfetalmembraneruptureneonatalsepsisandisexacerbatedbyerythromycin